Filing Details

Accession Number:
0001209191-14-002858
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-01-10 17:31:26
Reporting Period:
2013-12-10
Filing Date:
2014-01-10
Accepted Time:
2014-01-10 17:31:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1107332 Dendreon Corp DNDN Pharmaceutical Preparations (2834) 223203193
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1562381 Lindsay Rocco 1301 2Nd Ave
Seattle WA 98101
Evp, Corporate Communications No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-12-10 8,207 $2.94 112,500 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Beneficial ownership has been updated to include the restricted stock award granted on January 3, 2014 for 75,000 shares, as filed by Form 4 on January 7, 2014.